| Dr Paras A Shah, MD | |
|
1760 E Pecos Rd Ste 101, Gilbert, AZ 85295-3201 | |
| (913) 642-4900 | |
| (913) 381-0979 |
| Full Name | Dr Paras A Shah |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 1760 E Pecos Rd Ste 101, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720252844 | NPI | - | NPPES |
| 620906 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 40615 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Huhu Kam Memorial Hospital | Sacaton, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fresno Imaging Center | 2466553128 | 42 |
| Beverly Radiology Medical Group Iii | 3476466376 | 242 |
| Chandler Radiology Associates Llc | 4183600877 | 41 |
| Desert Advanced Imaging Medical Center | 6406749613 | 133 |
| Fresno Imaging Center | 2466553128 | 42 |
| Beverly Radiology Medical Group Iii | 3476466376 | 242 |
| Desert Advanced Imaging Medical Center | 6406749613 | 133 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Honorhealth Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043851793 PECOS PAC ID: 1557274057 Enrollment ID: O20031119000717 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Benson Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336118322 PECOS PAC ID: 3274443056 Enrollment ID: O20040109000537 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Navajo Health Foundation-sage Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477735777 PECOS PAC ID: 2163332347 Enrollment ID: O20040326001225 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Chandler Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386602076 PECOS PAC ID: 4183600877 Enrollment ID: O20040624001184 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | District Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20141029002601 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Desert Advanced Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568416147 PECOS PAC ID: 6406749613 Enrollment ID: O20170120001843 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Mdig Of Arizona, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477056661 PECOS PAC ID: 5294080891 Enrollment ID: O20180622001741 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Smi Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972004489 PECOS PAC ID: 3476696220 Enrollment ID: O20180829003142 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Health Diagnostics Of California A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104321959 PECOS PAC ID: 4284621525 Enrollment ID: O20200313001484 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Sonoran Radiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033745708 PECOS PAC ID: 3375964505 Enrollment ID: O20200526002412 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Imaging Associates Of New Mexico Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629592464 PECOS PAC ID: 4981970233 Enrollment ID: O20200611000082 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Arizona Diagnostic Radiology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336757699 PECOS PAC ID: 1658796859 Enrollment ID: O20200805001519 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Norcal Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003965997 PECOS PAC ID: 7911099346 Enrollment ID: O20230201002635 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Entity Name | Fresno Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659456499 PECOS PAC ID: 2466553128 Enrollment ID: O20230831001484 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paras A Shah, MD 10835 N 25th Ave, Ste 240, Phoenix, AZ 85029-3458 Ph: (602) 246-2584 | Dr Paras A Shah, MD 1760 E Pecos Rd Ste 101, Gilbert, AZ 85295-3201 Ph: (913) 642-4900 |
News Archive
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use of inappropriate types of drugs also occur. Psychotropic drugs, such as hypnotics, anxiolytics and antidepressant drugs, are common among the elderly.
Lawmakers have different ideas about financing the payroll tax break extension and the Medicare physician payment fix. One proposal getting a lot of attention is using war savings.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
Dr. Georg Hernandez, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4001 E Baseline Rd Ste 105, Gilbert, AZ 85234 Phone: 480-632-5378 Fax: 480-632-1821 | |
Yerko O Borghero, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-3676 Fax: 480-256-3608 | |
Dr. Joel R Meyer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Banner Md Anderson Cancer Center, 2940 E. Banner Gateway Drive Suite 350, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Sarah E Nicholas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Banner Md Anderson Cancer Center, 2946 E. Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Dr. Matthew D Callister, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 2940 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 | |
Dr. Philippe Lanauze, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Gary Walker, M.D., M.P.H., M.S. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-256-4500 |